What is the recommendation for primary prevention of cardiovascular risk in patients with a 10-year risk between 6-12%?
For primary prevention, we suggest offering a moderate-dose statin for patients with a 10-year cardiovascular risk between 6% and 12% following a discussion of risks, limited benefit, and an exploration of the patient's values and preferences.